Correlation Between United Therapeutics and Verastem

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both United Therapeutics and Verastem at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining United Therapeutics and Verastem into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between United Therapeutics and Verastem, you can compare the effects of market volatilities on United Therapeutics and Verastem and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in United Therapeutics with a short position of Verastem. Check out your portfolio center. Please also check ongoing floating volatility patterns of United Therapeutics and Verastem.

Diversification Opportunities for United Therapeutics and Verastem

-0.41
  Correlation Coefficient

Very good diversification

The 3 months correlation between United and Verastem is -0.41. Overlapping area represents the amount of risk that can be diversified away by holding United Therapeutics and Verastem in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Verastem and United Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on United Therapeutics are associated (or correlated) with Verastem. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Verastem has no effect on the direction of United Therapeutics i.e., United Therapeutics and Verastem go up and down completely randomly.

Pair Corralation between United Therapeutics and Verastem

Given the investment horizon of 90 days United Therapeutics is expected to under-perform the Verastem. But the stock apears to be less risky and, when comparing its historical volatility, United Therapeutics is 2.44 times less risky than Verastem. The stock trades about -0.1 of its potential returns per unit of risk. The Verastem is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest  590.00  in Verastem on November 9, 2024 and sell it today you would earn a total of  19.00  from holding Verastem or generate 3.22% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy95.24%
ValuesDaily Returns

United Therapeutics  vs.  Verastem

 Performance 
       Timeline  
United Therapeutics 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days United Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Even with latest weak performance, the Stock's technical indicators remain invariable and the latest agitation on Wall Street may also be a sign of long-running gains for the enterprise retail investors.
Verastem 

Risk-Adjusted Performance

OK

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Verastem are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, Verastem displayed solid returns over the last few months and may actually be approaching a breakup point.

United Therapeutics and Verastem Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with United Therapeutics and Verastem

The main advantage of trading using opposite United Therapeutics and Verastem positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if United Therapeutics position performs unexpectedly, Verastem can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Verastem will offset losses from the drop in Verastem's long position.
The idea behind United Therapeutics and Verastem pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.

Other Complementary Tools

Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm